Skip to main content

Clever Leaves Enters US Consumer CBD Market

JOYSOL™, a CBD brand developed by Clever Leaves’ US consumer packaged goods division, Herbal Brands, is now available online

JoySol Product Family

JoySol Product Family

JoySol Product Family

BOCA RATON, Fla., Jan. 26, 2022 (GLOBE NEWSWIRE) — Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, today announced its entrance to the U.S. CBD market through the launch of its consumer-oriented CBD line JoySol™. JoySol is produced by Arizona-based Herbal Brands, Inc. (“Herbal Brands”), an established consumer goods manufacturer, wholesaler and direct-to-consumer e-tailer and a wholly-owned subsidiary of Clever Leaves.

Clever Leaves’ consumer brands division is introducing JoySol with high-quality CBD, minor cannabinoids and proprietary terpene blends at a mass-market-accessible price point. JoySol launches with oil drop blends, gummies and topicals that comprise a unique CBD Daily Care System, with easy-to-use products specific to each segment of the day – morning, mid-day and evening. The CBD Daily Care System is now available at joysol.com.

“CBD is a rapidly growing segment in the self-care and wellness category, yet we believe there is a dearth of high-quality product offerings and brands for both early-adopters of CBD and consumers which have not yet adopted products containing CBD,” said Kyle Detwiler, CEO of Clever Leaves. “The launch of JoySol makes CBD easily accessible to the everyday individual via a direct-to-consumer approach that marks our entry into the U.S. cannabinoid consumer market.”

“We want everyday consumers, from school teachers to construction workers to stockbrokers, to get more out of life, so we have leveraged CBD and other cannabinoids along with exclusive terpene blends to help support the body and mind,” said Bonnie Brown, Herbal Brands VP of Marketing.

Clever Leaves acquired Herbal Brands in 2019. Since the acquisition, Herbal Brands has expanded its access to more than 20,000 retail distribution points in the U.S. through sales of its well-established nutraceutical products. Clever Leaves believes this provides a strategic entry point and competitive advantage to the U.S. market as cannabinoids become federally legal and regulated.

About Clever Leaves Holdings Inc.
Clever Leaves is a multinational cannabis company with an emphasis on ecologically sustainable, large-scale cultivation and pharmaceutical-grade cannabinoid processing as the cornerstones of its global cannabis business. With operations and investments in the United States, Canada, Colombia, Germany and Portugal, Clever Leaves has created an effective distribution network and global footprint, with a foundation built upon capital efficiency and rapid growth. Clever Leaves aims to be one of the industry’s leading global cannabis companies recognized for its principles, people, and performance while fostering a healthier global community. Clever Leaves has received multiple international certifications that have enabled it to increase its export and sales capacity from its Colombian operations, including European Union Good Manufacturing Practices (EU GMP) Certification, a Good Manufacturing Practices (GMP) Certification by Colombia National Food and Drug Surveillance Institute – Invima, and Good Agricultural and Collecting Practices (GACP) Certification. Clever Leaves was granted a license in Portugal from Infarmed – the Portuguese health authority – which allows Clever Leaves to cultivate, import and export dry flower for medicinal and research purposes. In addition, the Portuguese operation was also granted by Control Union Certifications to be compliant with GACP and GAP from EMEA and WHO, as well as with CUMCS – G.A.P.

For more information, visit https://cleverleaves.com/en/home/ and follow Clever Leaves on Twitter and LinkedIn.

About JoySol
JoySol is a brand from Herbal Brands, the US nutraceutical division of Clever Leaves, a multinational cannabis company with an emphasis on ecologically sustainable, large-scale cultivation of pharmaceutical-grade processing.

Clever Leaves Press Contacts:
McKenna Miller
KCSA Strategic Communications
+1-347-487-6197
mmiller@kcsa.com

Diana Sigüenza
Strategic Communications Director
+57-310-236-8830
diana.siguenza@cleverleaves.com

JoySol Press Contact:
Nikki Gersten
+1 503-317-9024
nikki.gersten@herbalbrands.com

JoySol Commercial Inquiries:
Angela Johnson
Vice President Sales – Herbal Brands
+1-828-490-8140
Angela.Johnson@herbalbrands.com

Clever Leaves Commercial Inquiries:
Andrew Miller
Vice President Sales – EMEA, North America, and Asia-Pacific
+1-416-817-1336
andrew.miller@cleverleaves.com

Clever Leaves Investor Inquiries:
Cody Slach and Jackie Keshner
Gateway Investor Relations
+1-949-574-3860
CLVR@gatewayir.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/6ed24f9f-248c-4303-956a-a8efb6a4c8c3.

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.